NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Dr. Gilbert Tang Shares NEJM Late-Breaker: 7-Year Outcomes Reinforce TAVR as a Durable Option for Low-Risk Aortic Stenosis
Dr. Gilbert Tang/X
Nov 13, 2025, 01:15

Dr. Gilbert Tang Shares NEJM Late-Breaker: 7-Year Outcomes Reinforce TAVR as a Durable Option for Low-Risk Aortic Stenosis

Dr. Gilbert Tang, Vice Chair of Innovation, Cardiovascular Surgery Surgical and Academic Director at Mount Sinai Health System, shared a post on X:

“TCT2025 Late breaker PARTNER 3 Low Risk 7 Year Sapien3 TAVR vs SAVR showed no significant differences in composite endpoint, all-cause mortality, CV mortality, and low reintervention rates in both arms. Clinical valve thrombosis 2.8% TAVR vs 0.5% SAVR but similar BVF (valve failure) and reintervention.

Paper now online The New England Journal of Medicine (NEJM)
and can download here.

Dr. Gilbert Tang Shares NEJM Late-Breaker: 7-Year Outcomes Reinforce TAVR as a Durable Option for Low-Risk Aortic Stenosis

Nice TCTMD article.”

Stay updated with Hemostasis Today.

Dr. Gilbert Tang Health Hematology Hemostasis Hemostasis Today Medicine PARTNER 3 SAVR TAVR TCT2025 The New England Journal of Medicine (NEJM)
NewsFeed